Results 161 to 170 of about 15,092,034 (255)

Clinical Impact of MGMT Promoter Methylation in IDH‐Mutant Gliomas: Influence of Threshold Selection and Clinical Confounding

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang, Linxi Cao, Xiaodong Chen, Siqi Tong, Qinghui Zhu, Jun Yang, Song Lin, Yong Cui   +7 more
wiley   +1 more source

Impact of deep learning model uncertainty on manual corrections to MRI-based auto-segmentation in prostate cancer radiotherapy. [PDF]

J Appl Clin Med Phys
Rogowski V, Svalkvist A, Maspero M, Janssen T, Maruccio FC, Gorgisyan J, Scherman J, Häggström I, Wåhlstrand V, Gunnlaugsson A, Nilsson MP, Moreau M, Vass N, Pettersson N, Gustafsson CJ.   +14 more
europepmc   +1 more source

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong, Yuping Xiao, Yuhan Wu, Ziyuan Huang, Weishan Liang, Li Xiao, Yaqing Shu, Tingting Lu, Yanyu Chang, Wei Qiu, Yuge Wang   +10 more
wiley   +1 more source

Systemic Extracerebral Atherosclerotic Burden and Dementia Risk After Incident Stroke

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Stroke survivors are at increased risk of dementia, but clinically accessible markers of risk heterogeneity remain limited. Previous studies have largely examined atherosclerotic disease in individual vascular beds rather than the overall burden of systemic extracerebral atherosclerosis.
Zhexuan Yu, Tianxue Chen, Wei Jin, Weifeng Jin, Haitong Wan   +4 more
wiley   +1 more source

An overview of model uncertainty and variability in LLM-based sentiment analysis: challenges, mitigation strategies, and the role of explainability. [PDF]

Front Artif Intell
Herrera-Poyatos D, Peláez-González C, Zuheros C, Herrera-Poyatos A, Tejedor V, Herrera F, Montes R.   +6 more
europepmc   +1 more source

Playoff Uncertainty, Match Uncertainty and Attendance at Australian National Rugby League Matches [PDF]

This paper develops a new simulation-based measure of playoff uncertainty and investigates its contribution to modelling match attendance compared to other variants of playoff uncertainty in the existing literature.
Nicholas King, Rick Audas, P Dorian Owen
core  

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Overcoming Model Uncertainty - How Equivalence Tests Can Benefit From Model Averaging. [PDF]

Stat Med
Hagemann N, Möllenhoff K.
europepmc   +1 more source

Welfare Cost of Model Uncertainty in a Small Open Economy. [PDF]

Entropy (Basel), 2020
Tapia Stefanoni J.
europepmc   +1 more source

Invocation of uncertainty

, 2014
I engage with uncertainty by imagining a visual culture that might look very different from what it is now. My imagining of the not-yet made starts with a series of questions: What would visual culture look like without the predictable rhetoric of ...
Gill, Alison (R7721)
core